ECigIntelligence

Regulatory and market intelligence for the e-cigarette sector

Regulatory briefing

Acting FDA chief Sharpless says the case for e-cigs is still unproven

Written by || 11th July 2019 || Regulatory briefing || FDA | Regulation and Legislation | North America United States

Acting US FDA commissioner Ned Sharpless has expressed his commitment to giving fair consideration to alternatives to smoking – but he still has doubts about vaping ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Related contents

Cancer Institute head Sharpless to follow Gottlieb as acting FDA chief
Sharpless keeps the FDA on its chosen path against youth vaping ‘epidemic’
FDA and the US vapour industry watching each other’s moves closely

Sign up to our newsletter

    By signing up you agree to our Privacy Policy.